Company profile
Personalised Neurofeedback for Mental Health Treatment
A medtech company developing neurofeedback Therapy technologies to address neurological and psychological diseases.
Financial period: 1 May 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
CS01 | Transaction MzUyNTc5MzUwMGFkaXF6a2N4
Published 07 Jun 2026 13:54
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Sep 2023 to 30 Jun 2025
The proposed COSMA neurofeedback system is a self-management solution but also a therapeutic system that provides a cognitive map response for each game played which includes (1) cognitive scores and (2) brain profile responses. The cognitive map produced will help the user, carer, and clinician to understand the patients' cognitive enhancement and the br...
1 Jan 2023 to 31 May 2023
Dementia is an increasing problem as people benefit from longer lifespans but lose cognitive senses and physical coordination with age. With medication only able to alleviate symptoms, the burden on the healthcare system and family support networks has grown rapidly. There are presently 47m people worldwide living with dementia and by 2030 this number wil...
1 Jan 2022 to 31 Mar 2022
There is an increasing proportion of the global population with memory problems, depression, space-time disorientation or decreased logical reasoning with aging. These onset symptoms may lead to early-stage neurodegenerative disorders e.g. dementia. As these conditions progress, the brainwave activities decline. Present drug treatments come with severe si...
1 Jun 2020 to 30 Nov 2020
no public description
1 Mar 2019 to 31 May 2020
"There is an increasing proportion of the global population with memory problems, depression, space-time disorientation or decreased logical reasoning with aging. These onset symptoms may lead to early-stage neurodegenerative disorders e.g. dementia. As these conditions progress, the brainwave activities decline. Present drug treatments come with severe s...
